Baird Financial Group Boosts Stake in Amgen
Baird Financial Group Inc., a prominent investment firm, increased its stake in Amgen Inc. by 1.6% during the second quarter.
According to the company's latest filing with the SEC, Baird Financial Group Inc. purchased an additional 5,496 shares of Amgen's stock, bringing its total holdings to 339,825 shares.
The firm's stake in Amgen is now valued at $123,057,000, accounting for 0.06% of the company's outstanding shares.